We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £498,020
CityFALCON is a data curation and structuring company that has received two six-figure grants, not included in the funded amount. It transforms unstructured financial content into structured data, generating analytics, extracting insights, and delivering personalised data to users and clients. CityFALCON is disrupting the £23 bn financial content market dominated by Yahoo Finance, Crunchbase, and Bloomberg with automation, long-tail coverage, and unrestricted access to our data via API and web at reasonable prices. The company's key clients include fintech companies such as BNP Paribas, IEX Group, and Seedrs. With the proceeds, the company will embark over 75% of the funds for salaries & technology costs and the rest will be used for marketing and premium content.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £602,201
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £70,900
SKOOT is a platform that connects friends who need lifts or errands, with friends who can help. The app auto-calculates fares for lifts taken and splits the costs. It also permits users to organise, request and arrange errands or simple favours from friends for free or a £5 tip. SKOOT claims to be the only carbon negative green navigation app for drivers. The company argues that it has also taken up the '1 Million Tree Challenge' and plants a tree for every journey on the platform. SKOOT is live on the Apple App Store and Google Playstore, with more than 18,000 users. It aims to become a contender in the ride-hailing industry that is worth $85.8 billion. SKOOT states it has raised £3.1 million from investors, won £75,000 from Innovate UK, and completed over 1,200 tasks to date using its 'Errands' feature launched during the COVID-19 pandemic. SKOOT states they will use the investment to extend its product, create more revenue streams and increase user activation across the EU, USA, Australia and Canada by early 2022.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £409,913
8dates is a dating recommendation engine and marketplace for new couples. The company's app uses machine learning to know what couples want when they first meet and shows them upcoming events by partner affiliates that they can engage in as per their interest. 8dates affiliate partners include OpenTable and Eventbrite. The company has also been granted the Facebook Dating License for advertising. It will use the investment to localise its offerings across key markets in the UK and Europe and grow its affiliate partnership program by adding more events. They will also develop the Android version of its application, acquire patents, copyrights, and IP expansion for its trademarks, app development, and UI/UX updates, and boost marketing and customer acquisition via Facebook, TikTok, Instagram, Spotify, and Pandora.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £357,242
The Fertility Circle (TFC) aspires to become the go-to channel for one in six couples that are struggling to conceive. It aims to help them via its app that consists of four core features namely, community guidance, expert help, knowledge sources, and holistic support channels. The company aims to become a contender in the fertility market that is projected to hit $41 billion by 2026. TFC asserts that it is supported by notable entities like Virgin Startup, FemTech Lab, and 'M' accelerators. TFC has featured in media entities like Grazia, Thomson Reuters, and Thrive Global and was included in Apple's ‘Hot Right Now' list being ranked second for 'Fertility Support' in the App Store. The company has witnessed a 40% Month-on-Month (MoM) user growth, over 6,000+ app downloads in 6 months, and a social community presence of 5,000 followers to date. TFC will use the investment to pilot with six leading fertility clinics to offer the application to their patients.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £391,372
TIME-TO-FIND is a reverse marketplace for luxury Swiss watches that helps customers locate the watch they want from the company's network of brand authorised stockists. The company's complimentary service allows customers to communicate with and compare authorised retailers without any commitment with a simple sign-up process. When the customer is ready to transact, they can choose TIME-TO-FIND's bespoke concierge service to hand-deliver their desired watch to their doorstep. Customers can also opt for the secure courier service from their chosen authorised stockist to their nominated delivery address. TIME-TO-FIND garnered £80,000 worth of sales at retail value in its pilot period from August to December 2019 with zero returns. TIME-TO-FIND will use the investment to create marketing and PR campaigns to boost sales, increase site visits to 500,000 within 2021-2022, improve its website's user experience, and hire key personnel.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £281,731
Uhive is a cryptocurrency-powered social network that aims to foster peer-to-peer (P2P) transactions, interest-based advertising, and the sale of in-app digital assets to maintain user privacy on its portal. The company argues that current social networks flood users' feeds with hidden agendas auctioning off their data to the highest bidder. Uhive intends to change this. It asserts that its content-discovery model allows users to choose and fine-tune the content they see by selecting 26 different interests. Content creators can use Uhive's paywall feature to earn, rewarding quality posts with cryptocurrency payments. The company's app consists of an advanced AI and recommendation engine, crypto wallet, and media streaming, to name a few. Uhive has onboarded 182,000 users and witnessed 5 million posts created by users on its platform. It will use 23% of the investment for operations, 55% for product development, 21% for marketing, and 1% for legal costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £815,530
Common Objective is a global B2B sourcing and information platform that rewards sustainable business through higher search rankings. The company aims at disrupting the $2trillion fashion industry as it has already used by 23k+ fashion professionals who work at leading brands and 1000’s of SME’s, from over 150 countries. The company’s online platform uses personalisation and matching technology to connect buyers with suppliers and provides them with targeted content and tools supporting best practice. The site is used by individuals and teams who work at world-leading brands backed by industry leaders including Roland Mouret, PDS Multinational, and Plexus Cotton.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £462,260
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £522,689
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph